financetom
Business
financetom
/
Business
/
Alpha Cognition Launches Zunveyl for Treating Alzheimer's Disease; Shares Up Pre-Bell
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Alpha Cognition Launches Zunveyl for Treating Alzheimer's Disease; Shares Up Pre-Bell
Mar 18, 2025 6:12 AM

08:50 AM EDT, 03/18/2025 (MT Newswires) -- Alpha Cognition ( ACOG ) said Tuesday it has commercially launched Zunveyl for the treatment of mild to moderate Alzheimer's disease.

The company said the official commercial launch provides patients with access to 5 mg, 10 mg and 15 mg doses of the treatment through a prescription.

Shares of Alpha Cognition ( ACOG ) were more than 13% higher in recent premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved